References for this Section
1. Lanctot KL, Herrmann N, Yau KK, Khan LR, Liu BA, Loulou MM et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's Disease: a meta analysis. Canadian Medical Association Journal 2003; 169(6):557-64.
2. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP. Cholinesterase inhibitors for patients with Alzheimer's Disese: systematic review of randomised clinical trials. BMJ 2005; 331(7512):321-7.
3. Hanon O, Forette F. Treatment of hypertension and prevention of dementia. Alzheimer's and Dementia 2005; 1:30-7.
4. Schneider, LS, Loy C, Birks J, Hermans D, Insel P, McShane R. Cholinesterase inhibitors are associated with differential risks for death in vascular dementia and in severe Alzheimer's Disease. Alzheimer Association's International Conference on Alzheimer's Disease and Related Disorders; 2006 July 15-20; Madrid, Spain.
5. Reisberg B, Doody R, Stoffler A. Memantine in moderate-to-severe Alzheimer´s disease. N Engl J Med 2003;348(14):1333-41.
6. Winblad B, Poritis N. Memantine in severe dementia: Results of the 9M-Best Study. Int J Geriatr Psychiatry 1999; 14:135-46.
7. Boche D, Nicoll J, Weller R. Immunotherapy for Alzheimer’s Disease and other dementias. Current Opinion in Neurology 2005; 18(6): 720–725.
8. Orgogozo JM, Gilman S, Dartigues JF. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003; 61:46–54.
9. Luijpen MW, Scherder EJ, Van Someren EJ, Swaab DF, Sergeant JA. Non-pharmacological interventions in cognitively impaired and demented patients-a comparison with cholinesterase inhibitors. Reviews in Neurosciences 2003; 14(4):343-68.
10. Haywood WM, Mukaetova-Ladinska EB. Sex influences on cholinestrase inhibitor treatment in elderly individuals with Alzheimer's disease. The American Journal of Geriatric Pharmacology September 2006;273-286.
11. Patterson CJS, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Canadian Medical Association Journal 1999; 160 Suppl 12:S1-15.
12. The Centre for Disease Control and Prevention, USA http://www.cdc.gov/ncipc/duip/preventadultfalls.htm accessed September 14, 2007
13. Health Canada http://www.hc-sc.gc.ca/iyh-vsv/life-vie/fp-pc_e.html accessed September 14, 2007
